Erisik D, Ozdil B, Acikgoz E, Abdikan C, Yesin T, Aktug H
ACS Omega. 2023; 8(33):30145-30157.
PMID: 37636966
PMC: 10448492.
DOI: 10.1021/acsomega.3c02681.
Han S, Kim J, Kim M, Kim J, Lee K, Kim B
Oncol Lett. 2019; 17(6):5572-5580.
PMID: 31186779
PMC: 6507487.
DOI: 10.3892/ol.2019.10234.
Munksgaard Thoren M, Masoumi K, Krona C, Huang X, Kundu S, Schmidt L
Cancers (Basel). 2019; 11(4).
PMID: 31027305
PMC: 6521287.
DOI: 10.3390/cancers11040587.
Zhang H, Wang P, Lu M, Zhang S, Zheng L
Oncol Lett. 2019; 17(5):4487-4493.
PMID: 30944638
PMC: 6444394.
DOI: 10.3892/ol.2019.10081.
Rosiq S, Hammam O, Abdelalim A, Anas A, Khalil H, Amer M
Open Access Maced J Med Sci. 2018; 6(6):968-974.
PMID: 29983786
PMC: 6026422.
DOI: 10.3889/oamjms.2018.208.
R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
Ye J, Liu S, Shang Y, Chen H, Wang R
Cell Cycle. 2018; 17(8):1014-1025.
PMID: 29886802
PMC: 6103697.
DOI: 10.1080/15384101.2018.1469874.
Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
Usui T, Sakurai M, Umata K, Elbadawy M, Ohama T, Yamawaki H
Int J Mol Sci. 2018; 19(4).
PMID: 29642386
PMC: 5979580.
DOI: 10.3390/ijms19041098.
Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.
Wei X, Ye J, Shang Y, Chen H, Liu S, Liu L
Oncotarget. 2018; 8(65):109301-109318.
PMID: 29312609
PMC: 5752522.
DOI: 10.18632/oncotarget.22673.
Therapeutic strategies against cancer stem cells in human colorectal cancer.
Szarynska M, Olejniczak A, Kobiela J, Spychalski P, Kmiec Z
Oncol Lett. 2017; 14(6):7653-7668.
PMID: 29250169
PMC: 5727596.
DOI: 10.3892/ol.2017.7261.
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.
AlShamaileh H, Wang T, Xiang D, Yin W, Tran P, Barrero R
Sci Rep. 2017; 7(1):5898.
PMID: 28724889
PMC: 5517644.
DOI: 10.1038/s41598-017-05859-z.
Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
Karatas O, Suer I, Yuceturk B, Yilmaz M, Oz B, Guven G
BMC Cancer. 2016; 16(1):853.
PMID: 27816053
PMC: 5097853.
DOI: 10.1186/s12885-016-2863-3.
Rab27A mediated by NF-κB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion.
Feng F, Jiang Y, Lu H, Lu X, Wang S, Wang L
Oncotarget. 2016; 7(39):63342-63351.
PMID: 27556511
PMC: 5325368.
DOI: 10.18632/oncotarget.11454.
Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
Wei T, Lin Y, Chen W, Luo P, Lin Y, Shun C
EBioMedicine. 2016; 10:124-36.
PMID: 27448759
PMC: 5006731.
DOI: 10.1016/j.ebiom.2016.07.019.
Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.
Yang H, Peng T, Li J, Wang Y, Zhang W, Zhang P
Gene Ther. 2016; 23(5):450-9.
PMID: 26871935
DOI: 10.1038/gt.2016.15.
Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.
Carstens M, Fisher R, Acharya A, Butterworth E, Scott E, Huang E
Proc Natl Acad Sci U S A. 2015; 112(28):8732-7.
PMID: 26124098
PMC: 4507198.
DOI: 10.1073/pnas.1505374112.
Stem cells, colorectal cancer and cancer stem cell markers correlations.
Cherciu I, Barbalan A, Pirici D, Margaritescu C, Saftoiu A
Curr Health Sci J. 2015; 40(3):153-61.
PMID: 25729599
PMC: 4340434.
DOI: 10.12865/CHSJ.40.03.01.
Functional modification of adipocytes by grape seed extract impairs their pro-tumorigenic signaling on colon cancer stem cells and the daughter cancer cells.
Kumar S, Kumar D, Raina K, Agarwal R, Agarwal C
Oncotarget. 2014; 5(20):10151-69.
PMID: 25294814
PMC: 4259412.
DOI: 10.18632/oncotarget.2467.
Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
Kumar S, Raina K, Agarwal C, Agarwal R
Oncotarget. 2014; 5(13):4972-89.
PMID: 24970802
PMC: 4148115.
DOI: 10.18632/oncotarget.2068.
DNA methyltransferases: a novel target for prevention and therapy.
Subramaniam D, Thombre R, Dhar A, Anant S
Front Oncol. 2014; 4:80.
PMID: 24822169
PMC: 4013461.
DOI: 10.3389/fonc.2014.00080.
Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?.
Paldino E, Tesori V, Casalbore P, Gasbarrini A, Puglisi M
Biomed Res Int. 2014; 2014:859871.
PMID: 24527460
PMC: 3914574.
DOI: 10.1155/2014/859871.